flipper44
12 minutes ago
Cost Effectiveness.
If NWBO has been planning, for years, to demonstrate through CDF data collection financial support, that DCVax-l, when manufacturing closed and automated by Eden, is Cost Effective, then:
The several months NWBO has spent with a pharmaceutical compan